Absorption |
Blood-Brain Barrier | BBB- | 0.9823 |
Human Intestinal Absorption | HIA+ | 0.7379 |
Caco-2 Permeability | Caco2- | 0.7273 |
P-glycoprotein Substrate | Substrate | 0.5819 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9194 |
Non-inhibitor | 0.8007 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8794 |
Distribution |
Subcellular localization | Mitochondria | 0.3655 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8040 |
CYP450 2D6 Substrate | Non-substrate | 0.8281 |
CYP450 3A4 Substrate | Non-substrate | 0.5393 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.7490 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8202 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9005 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7881 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7951 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9449 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9903 |
Non-inhibitor | 0.9180 |
AMES Toxicity | Non AMES toxic | 0.7835 |
Carcinogens | Non-carcinogens | 0.8563 |
Fish Toxicity | High FHMT | 0.9169 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9406 |
Honey Bee Toxicity | Low HBT | 0.6482 |
Biodegradation | Not ready biodegradable | 0.9906 |
Acute Oral Toxicity | IV | 0.5401 |
Carcinogenicity (Three-class) | Non-required | 0.5262 |